The potential immunological mechanisms of sepsis
Top Cited Papers
Open Access
- 8 July 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1434688
Abstract
Sepsis is described as a life-threatening organ dysfunction and a heterogeneous syndrome that is a leading cause of morbidity and mortality in intensive care settings. Severe sepsis could incite an uncontrollable surge of inflammatory cytokines, and the host immune system's immunosuppression could respond to counter excessive inflammatory responses, characterized by the accumulated anti-inflammatory cytokines, impaired function of immune cells, over-proliferation of myeloid-derived suppressor cells and regulatory T cells, depletion of immune effector cells by different means of death, etc. In this review, we delve into the underlying pathological mechanisms of sepsis, emphasizing both the hyperinflammatory phase and the associated immunosuppression. We offer an in-depth exploration of the critical mechanisms underlying sepsis, spanning from individual immune cells to a holistic organ perspective, and further down to the epigenetic and metabolic reprogramming. Furthermore, we outline the strengths of artificial intelligence in analyzing extensive datasets pertaining to septic patients, showcasing how classifiers trained on various clinical data sources can identify distinct sepsis phenotypes and thus to guide personalized therapy strategies for the management of sepsis. Additionally, we provide a comprehensive summary of recent, reliable biomarkers for hyperinflammatory and immunosuppressive states, facilitating more precise and expedited diagnosis of sepsis.Keywords
This publication has 153 references indexed in Scilit:
- Immunopathology of chronic critical illness in sepsis survivors: Role of abnormal myelopoiesisJournal of Leukocyte Biology, 2022
- Metabolic reprogramming consequences of sepsis: adaptations and contradictionsCellular and Molecular Life Sciences, 2022
- Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumabIntensive Care Medicine, 2019
- Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for SepsisJAMA, 2019
- Intestinal Microbiota Mediates the Susceptibility to Polymicrobial Sepsis‐Induced Liver Injury by Granisetron Generation in MiceHepatology, 2018
- Fluid administration in severe sepsis and septic shock, patterns and outcomes: an analysis of a large national databaseIntensive Care Medicine, 2017
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Immunosuppression in Patients Who Die of Sepsis and Multiple Organ FailureJAMA, 2011
- Profound and persistent decrease of circulating dendritic cells is associated with ICU-acquired infection in patients with septic shockIntensive Care Medicine, 2011
- Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shockIntensive Care Medicine, 2010